Logo 1 Logo 2

Clinical Trial Details

Trial ID: L2148
Source ID: NCT03552991
Associated Drug: Agiocur Pregranules
Title: Effects of Dietary Fiber on Glucose Control in Subjects With Type 2 Diabetes Mellitus
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus, Type 2
Interventions: DRUG: Agiocur Pregranules
Outcome Measures: Primary: Fasting glucose, By comparing the level of 4th week, compared to baseline, the 4th week of study|Glycoalbumin, By comparing the level of 4th week, compared to baseline, the 4th week of study|Insulinogenic index, By comparing the level of 4th week, compared to baseline, the 4th week of study|Quantitative insulin sensitivity check index (QUICKI), By comparing the level of 4th week, compared to baseline. QUICKI is derived from fasting blood glucose and insulin level, reflecting insulin sensitivity., the 4th week of study | Secondary: Microbiota composition change, By comparing the level of 4th week, compared to baseline, the 4th week of study|Incretins (GIP), By comparing the level of 4th week, compared to baseline, the 4th week of study|Incretins (GLP-1), By comparing the level of 4th week, compared to baseline, the 4th week of study|Incretins (GLP-2), By comparing the level of 4th week, compared to baseline, the 4th week of study|Lipopolysaccharide (LPS), By comparing the level of 4th week, compared to baseline, the 4th week of study
Sponsor/Collaborators: Sponsor: Samsung Medical Center | Collaborators: Bukwang Pharmaceutical, Co., Ltd.|ChunLab, Inc.
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE4
Enrollment: 14
Study Type: INTERVENTIONAL
Study Designs: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Start Date: 2014-02
Completion Date: 2018-05-31
Results First Posted:
Last Update Posted: 2018-06-12
Locations:
URL: https://clinicaltrials.gov/show/NCT03552991

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress